IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates01-12-2021
01-12-2021
IOL Chemicals hits fresh 52-week low, stock down 50% from life-time high
For H1FY22, the company's profit after tax declined 62 per cent year on year to Rs 97.80, due to higher operational cost.30-11-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates29-11-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates26-11-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Conference Call organized by the Company on 16th November 2021 post declaration of audited financial results for the quarter and half year ended 30th September 2021.22-11-2021
Earnings Call for Q2FY22 of IOL Chemicals and Pharmaceuticals
Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.16-11-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation Q2 FY2215-11-2021
Q2FY22 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.
Highlights: IOL Chemicals and Pharmaceuticals Limited a leading manufacturer of pharmaceutical (APis) and specialty chemicals today posted its financial results for the quarter and half year ending 30th September 2021. The Company on QoQ basis recorded 5% growth in total income, however the EBITDA has been declined by about 53% on QoQ basis. Dr Sanjay Chaturvedi, Chief Executive Officer said ''During the quarter ended September 2021, the Company's performance has been muted presently due to contraction in flagship API demand and volatility in raw material prices of Chemical products. He further stated that revenue from new products in pharma API has been getting positive response." Result PDF15-11-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of analyst/ investors conference call - Q2 FY2213-11-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of analyst/ investors conference call - Q2 FY2213-11-2021